Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults
ISRCTN45828668 是一项针对成人进展性恶性胶质瘤的柳氮磺胺吡啶治疗的 1/2 期前瞻性随机研究，该研究已提前终止。
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/1471-2407-9-372
Robe, Pierre A; Martin, Didier H; Nguyen-Khac, Minh T; Artesi, Maria; Deprez, Manuel; Albert, Adelin; Vanbelle, Sophie; Califice, Stephane; Bredel, Markus; Bours, Vincent
